相关实验视频

Updated: Sep 17, 2025

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Published on: May 6, 2020

西洛利木斯是一种水溶性mTOR抑制剂,可以缓解人体肌肉细胞和小鼠骨关节炎模型的骨关节炎变化

Yuhei Otsuki¹, Takehiko Matsushita¹, Akiyoshi Mori¹

¹Department of Orthopedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Connective tissue research

|June 30, 2025

概括

在小鼠中,关节内西罗利保护人体肌肉细胞,并延迟了骨关节炎的进展. 这种mTOR抑制剂在治疗关节软骨退化和骨关节炎方面表现有前途.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
整形外科整形外科整形外科

背景情况:

骨关节炎 (OA) 是一种退行性关节疾病,其特征是关节软骨的破坏.
猛素 (mTOR) 信号传递的哺乳动物点在软骨细胞功能和OA病变发生方面发挥着作用.
作为一种mTOR抑制剂的西罗利木斯是水溶性的,适合于关节内给药.

研究的目的:

评估内内西洛利木斯对人体冠状细胞的治疗效果.
在小鼠模型中评估关节内西洛利木斯对骨关节炎进展的影响.

主要方法:

人类红细胞被用temsirolimus在体外治疗,有或没有IL-1β刺激.
他们分析了基因表达 (COL2A1,aggrecan,MMPs,ADAMTSs),亡和自.
在小鼠中诱导了OA (手术模型和SAMP8),并给出了关节内西洛斯.
在小鼠膝关节上进行了组织学和免疫组织化学分析.

主要成果:

西洛利斯在人体冠状细胞中调高了COL2A1和aggrecan的表达.
它逆转了IL-1β诱导的软骨矩阵基因下调,并降低了代谢性基因表达.
西洛斯降低了细胞亡,并增强了细胞的自性.
在小鼠模型中,Temsirolimus的关节内注射延迟了OA的进展.

结论:

泰米西罗利斯可以保护人体红细胞免受IL-1β诱导的损伤和亡.
在活体中,关节内西洛斯的使用有效地延迟了骨关节炎的进展.
关节内西洛利木斯是一种潜在的治疗策略,可以抑制关节软骨的退化.

关键词:

骨关节炎是一种骨关节炎.冠状腺细胞冠状腺细胞通过关节内给药.这是一种mTOR抑制剂.这就是Temsirolimus.

更多相关视频

The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse

The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse

Published on: May 16, 2016

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...